Advertisement
Case report| Volume 21, ISSUE 4, P398-401, April 1986

Persistent supersensitivity vomiting following neuroleptic withdrawal in an adolescent

  • Charles S. Grob
    Correspondence
    Address reprint requests to Dr. Charles S. Grob, Division of Child Psychiatry, Departments of Psychiatry and Pediatrics CMSC 335, The Johns Hopkins University, School of Medicine, 600 N Wolfe Street, Baltimore, MD 21205.
    Affiliations
    From the Division ot Child Psychiatry, Departments of Psychiatry and Pediatrics, The Johns Hopkins University, School of Medicine, Baltimore, MDUSA
    Search for articles by this author
      This paper is only available as a PDF. To read, Please Download here.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Biological Psychiatry
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Brooks GM
        Withdrawal from neuroleptic drugs.
        Am J Psychiatry. 1959; 115: 931-932
        • Byck R
        Drugs and the treatment of psychiatric disorders.
        in: Goodman CS Gilman A The Pharmacologic Basis of Therapeutics. ed 5. MacMillen, New York1975: 152-200
        • Chouinard G
        • Jones BD
        Neuroleptic-induced supersensitivity psychosis: Clinical and phar macological characteristics.
        Am J Psychiatry. 1980; 137: 16-21
        • Chouinard G
        • Bradwein J
        • Annable L
        • Jones BD
        • Ross-Chouinard A
        Withdrawal symptoms after long-term treatment with low-potency neuroleptics.
        J Clin Psychiatry. 1984; 45: 500-502
        • Gallant DM
        • Edwards CG
        • Bishop MP
        • Galbraith GC
        Withdrawal symptoms after abrupt cessation of antipsychotic compounds: Clinical confirmation in chronic schizophrenics.
        Am J Psychiatry. 1964; 121: 491-493
        • Gardos G
        • Cole JO
        • Tarsy D
        Withdrawal symptoms associated with antipsychotic drugs.
        Am J Psychiatry. 1978; 135: 1321-1324
        • Gualtieri CT
        • Quade D
        • Hicks RE
        • Mayo JP
        • Schroeder SR
        Tardive dyskinesia and other clinical consequences of neuroleptic treatment in children and adolescents.
        Am J Psychiatry. 1984; 141: 20-23
        • Innes IR
        • Nickerson M
        Atropine, scopolamine and related antimuscarinic drugs.
        in: Goodman CS Gillman A The Pharmacologic Basis of Therapeutics. ed 5. MacMillen, New York1975: 514-532
        • Kent TA
        • Wilber RD
        Single case study. Reserpine withdrawal psychosis: The possible role of denervation supersensitivity of receptors.
        J Nerv Ment Dis. 1982; 170: 502-504
        • Lacoursiere RB
        • Spohn HD
        • Thompson K
        Medical effects of abrupt neuroleptic withdrawal.
        Compr Psychiatry. 1976; 17: 285-294
        • Luchin DJ
        • Freed WJ
        • Wyatt RJ
        The role of cholinergic supersensitivity in the medical symptoms associated with withdrawal of antipsychotic drugs.
        Am J Psychiatry. 1980; 137: 1395-1398
        • Melnyk WT
        • Worthington AG
        • Laverty SG
        Abrupt withdrawal of chlorpromazine and thioridazine from schizophrenic inpatients.
        Can Psychiatr Assoc J. 1966; 11: 410-413
        • Shen WW
        • Baig MSA
        • Sata LS
        • Hoffstatter L
        Dopamine receptor supersensitivity and the chemoreceptor trigger zone.
        Biol Psychiatry. 1983; 18: 917-921
        • Yepes LE
        • Winsberg BG
        Vomiting during neuroleptic withdrawal in children.
        Am J Psychiatry. 1977; 134: 574